UroGen Pharma Reveals Promising Developments in Latest 8-K Filing
UroGen Pharma Ltd., a pioneering pharmaceutical company with a focus on innovative treatments for urothelial cancers, recently submitted an 8-K form to the Securities and Exchange Commission, highlighting significant events as of January 14, 2025. The filing details the submission of a presentation by UroGen Pharma, which may be utilized in engagements with investors and […]
More Stories
PIMCO California Municipal Income Fund II (NYSE:PCK) Short Interest Update
PIMCO California Municipal Income Fund II (NYSE:PCK – Get Free Report) was the target of a significant growth in short...
The LGL Group, Inc. (NYSEAMERICAN:LGL) Short Interest Down 38.7% in December
The LGL Group, Inc. (NYSEAMERICAN:LGL – Get Free Report) was the target of a large decline in short interest during...
GREE, Inc. (OTCMKTS:GREZF) Sees Significant Increase in Short Interest
GREE, Inc. (OTCMKTS:GREZF – Get Free Report) saw a significant increase in short interest in the month of December. As...
National Security Emerging Markets Index ETF (NASDAQ:NSI) Short Interest Down 40.0% in December
National Security Emerging Markets Index ETF (NASDAQ:NSI – Get Free Report) was the target of a large drop in short...
Luvu Brands, Inc. (OTCMKTS:LUVU) Short Interest Update
Luvu Brands, Inc. (OTCMKTS:LUVU – Get Free Report) saw a significant decline in short interest in December. As of December...
Peyto Exploration & Development (OTCMKTS:PEYUF) Stock Price Up 1.4% – What’s Next?
Shares of Peyto Exploration & Development Corp. (OTCMKTS:PEYUF – Get Free Report) traded up 1.4% during trading on Tuesday ....